E7 proteins from high- and low-risk human papillomaviruses bind to TGF-β-regulated Smad proteins and inhibit their transcriptional activity

Archives of Virology

Volumn 151, Issue 10, 2006, Pages 1961-1972

  Habig, M ^a   Smola, H ^a   Dole, V S ^a   Derynck, R ^b   Pfister, H ^a   Smola Hess, S ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E7; SMAD PROTEIN;

ARTICLE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; GENETICS; KERATINOCYTE; METABOLISM; PAPILLOMA VIRUS; TRANSACTIVATION; TRANSCRIPTION INITIATION; VERRUCA VULGARIS; VIROLOGY;

CELL PROLIFERATION; KERATINOCYTES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS; SMAD PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTIONAL ACTIVATION; WARTS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 33748972276     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-006-0768-1     Document Type: Article

References (48)

1. MJ Antinore MJ Birrer D Patel L Nader DJ McCance 1996 The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors EMBO J 15 1950 1960
2. A Bernat N Avvakumov JS Mymryk L Banks 2003 Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300 Oncogene 22 7871 7881
3. RA Blanton MD Coltrera AM Gown CL Halbert JK McDougall 1992 Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels Cell Growth Differ 3 791 802
4. L Choy R Derynck 1998 The type II transforming growth factor (TGF)-beta receptor-interacting protein TRIP-1 acts as a modulator of the TGF-beta response J Biol Chem 273 31455 31462
5. JC Chrivia RP Kwok N Lamb M Hagiwara MR Montminy RH Goodman 1993 Phosphorylated CREB binds specifically to the nuclear protein CBP Nature 365 855 859
6. F Ciccolini G Di Pasquale F Carlotti L Crawford M Tommasino 1994 Functional studies of E7 proteins from different HPV types Oncogene 9 2633 2638
7. RJ Coffey Jr CC Bascom NJ Sipes R Graves-Deal BE Weissman HL Moses 1988 Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta Mol Cell Biol 8 3088 3093
8. R Derynck YE Zhang 2003 Smad-dependent and Smad-independent pathways in TGF-beta family signalling Nature 425 577 584
9. J Doorbar 2005 The papillomavirus life cycle J Clin Virol 32 Suppl 1 S7 S15
10. N Dyson PM Howley K Münger E Harlow 1989 The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 243 934 937
11. N Dyson P Guida K Münger E Harlow 1992 Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins J Virol 66 6893 6902
12. C Enzenauer G Mengus A Lavigne I Davidson H Pfister M May 1998 Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex Intervirology 41 80 90
13. XH Feng Y Zhang RY Wu R Derynck 1998 The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation Genes Dev 12 2153 2163
14. XH Feng X Lin R Derynck 2000 Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta EMBO J 19 5178 5193
15. M Giarre S Caldeira I Malanchi F Ciccolini MJ Leao M Tommasino 2001 Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle Arrest J Virol 75 4705 4712
16. LI Gold T Jussila NE Fusenig F Stenback 2000 TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis J Pathol 190 579 588
17. MS Gruschwitz OP Hornstein 1992 Expression of transforming growth factor type beta on human epidermal dendritic cells J Invest Dermatol 99 114 116
18. D Hadaschik K Hinterkeuser M Oldak HJ Pfister S Smola-Hess 2003 The Papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation J Virol 77 5253 5265
19. H Hanafusa J Ninomiya-Tsuji N Masuyama M Nishita J Fujisawa H Shibuya K Matsumoto E Nishida 1999 Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression J Biol Chem 274 27161 27167
20. GJ Hannon D Beach 1994 p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest Nature 371 257 261
21. R Janknecht NJ Wells T Hunter 1998 TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300 Genes Dev 12 2114 2119
22. TC Ko W Yu T Sakai H Sheng J Shao RD Beauchamp EA Thompson 1998 TGF-beta1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expression Oncogene 16 3445 3454
23. DK Lee BC Kim IY Kim EA Cho DJ Satterwhite SJ Kim 2002 The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of the Smad complex to its target sequence J Biol Chem 277 38557 38564
24. X Liu Y Sun SN Constantinescu E Karam RA Weinberg HF Lodish 1997 Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells Proc Natl Acad Sci USA 94 10669 10674
25. ME McLaughlin-Drubin JL Bromberg-White C Meyers 2005 The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle Virology 338 61 68
26. K Middleton W Peh S Southern H Griffin K Sotlar T Nakahara A El-Sherif L Morris R Seth M Hibma D Jenkins P Lambert N Coleman J Doorbar 2003 Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers J Virol 77 10186 10201
27. K Münger BA Werness N Dyson WC Phelps E Harlow PM Howley 1989 Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product EMBO J 8 4099 4105
28. WL Peh K Middleton N Christensen P Nicholls K Egawa K Sotlar J Brandsma A Percival J Lewis WJ Liu J Doorbar 2002 Life cycle heterogeneity in animal models of human papillomavirus-associated disease J Virol 76 10401 10416
29. Pfister H (2003) Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr: 52-56
30. JA Pietenpol RW Stein E Moran P Yaciuk R Schlegel RM Lyons MR Pittelkow K Munger PM Howley HL Moses 1990 TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains Cell 61 777 785
31. K Polyak JY Kato MJ Solomon CJ Sherr J Massague JM Roberts A Koff 1994 p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest Genes Dev 8 9 22
32. C Pouponnot L Jayaraman J Massague 1998 Physical and functional interaction of SMADs and p300/CBP J Biol Chem 273 22865 22868
33. Y Sano J Harada S Tashiro R Gotoh-Mandeville T Maekawa S Ishii 1999 ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling J Biol Chem 274 8949 8957
34. DJ Satterwhite ME Aakre AE Gorska HL Moses 1994 Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells Cell Growth Differ 5 789 799
35. ID Schaper GP Marcuzzi SJ Weissenborn HU Kasper V Dries N Smyth P Fuchs H Pfister 2005 Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8 Cancer Res 65 1394 1400
36. M Scheffner K Munger JC Byrne PM Howley 1991 The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines Proc Natl Acad Sci USA 88 5523 5527
37. A Schmitt JB Harry B Rapp FO Wettstein T Iftner 1994 Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1 J Virol 68 7051 7059
38. PH Smits L de Wit AJ van der Eb A Zantema 1996 The adenovirus E1A-associated 300∈kDa adaptor protein counteracts the inhibition of the collagenase promoter by E1A and represses transformation Oncogene 12 1529 1535
39. S Smola-Hess HJ Pfister 2002 Interaction of papillomaviral oncoproteins with cellular factors E Bogner A Holzenburg Structure-function relationships of human pathogenic viruses Kluver Academic/Plenum Publishers New York
40. S Smola-Hess J Pahne C Mauch P Zigrino H Smola HJ Pfister 2005 Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products J Gen Virol 86 1291 1296
41. RW Stein M Corrigan P Yaciuk J Whelan E Moran 1990 Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity J Virol 64 4421 4427
42. SM Stirdivant JD Ahern A Oliff DC Heimbrook 1992 Retinoblastoma protein binding properties are dependent on 4 cysteine residues in the protein binding pocket J Biol Chem 267 14846 14851
43. P ten Dijke CS Hill 2004 New insights into TGF-beta-Smad signalling Trends Biochem Sci 29 265 273
44. JN Topper MR DiChiara JD Brown AJ Williams D Falb T Collins MA Gimbrone Jr 1998 CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor beta transcriptional responses in endothelial cells Proc Natl Acad Sci USA 95 9506 9511
45. C Wong EM Rougier-Chapman JP Frederick MB Datto NT Liberati JM Li XF Wang 1999 Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta Mol Cell Biol 19 1821 1830
46. K Yagi M Furuhashi H Aoki D Goto H Kuwano K Sugamura K Miyazono M Kato 2002 c-myc is a downstream target of the Smad pathway J Biol Chem 277 854 861
47. Y Zhang XH Feng R Derynck 1998 Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription Nature 394 909 913
48. H zur Hausen 2002 Papillomaviruses and cancer: from basic studies to clinical application Nat Rev Cancer 2 342 350